Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials

Acad Radiol. 1996 Aug:3 Suppl 2:S173-5. doi: 10.1016/s1076-6332(96)80525-3.

Authors

J A Frank¹, C Bash, L Stone, J Petrella, H Maloni, H McFarland

Affiliation

¹ Laboratory of Diagnostic Radiology Research, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD, USA.

PMID: 8796554
DOI: 10.1016/s1076-6332(96)80525-3

No abstract available

MeSH terms

Adjuvants, Immunologic / therapeutic use*
Adult
Brain / drug effects
Brain / pathology
Contrast Media*
Drug Combinations
Female
Gadolinium DTPA
Humans
Image Enhancement*
Interferon beta-1a
Interferon beta-1b
Interferon-beta / therapeutic use*
Magnetic Resonance Imaging*
Male
Meglumine*
Middle Aged
Multiple Sclerosis / diagnosis*
Multiple Sclerosis / drug therapy
Nerve Fibers, Myelinated / drug effects
Nerve Fibers, Myelinated / pathology
Organometallic Compounds*
Pentetic Acid / analogs & derivatives*

Substances

Adjuvants, Immunologic
Contrast Media
Drug Combinations
Organometallic Compounds
Interferon beta-1b
Meglumine
Interferon-beta
Pentetic Acid
Gadolinium DTPA
Interferon beta-1a